Q9ERZ4 Muscarinic acetylcholine receptor M2 MolNFT, Molecular NFT on GenesisL1

Muscarinic acetylcholine receptor M2

MOLNFT AF v1 smart contract in GenesisL1 blockchain:

0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD

IPFS of NFT metadata:

bafybeia5f343b3443qvgpwhjzokai3st6npcc2e62d5455wtq7qmubmode/metadata.json

IPFS of structure file:

bafybeiccivfd7tc4l4erfw5jkzbpoapvogdgixzmrtvndhzzh6iofvsqx4/AF-Q9ERZ4-F1-model_v2.pdb

First NFT owner address (eip-55):

0x15Ecc076Aef3e102dDDA7B6F6fC88A40eA84aE39

First NFT owner address (bech32):

genesis1zhkvqa4w70ss9hw60dhkljy2gr4gft3egefnh4

Current NFT ID #6373 owner (web3):

0x15Ecc076Aef3e102dDDA7B6F6fC88A40eA84aE39

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
6373
Accession (UniProt):
Q9ERZ4
Name::
Muscarinic acetylcholine receptor M2
Experimental Method:
Predicted structure
Sequence source:
MUS MUSCULUS

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q9ERZ4 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q9ERZ4|ACM2_MOUSE Muscarinic acetylcholine receptor M2 OS=Mus musculus OX=10090 GN=Chrm2 PE=1 SV=2 MNNSTNSSNNGLAITSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIKKEKKEPVANQDPVSPSLVQGRIVKPNNNNMPGGDGGLEHNKIQNGKAPRDGGTENCVQGEEKESSNDSTSVSAVASNMRDDEITQDENTVSTSLGHSKDDNSRQTCIKIVTKTQKGDACTPTSTTVELVGSSGQNGDEKQNIVARKIVKMTKQPAKKKPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATR

Q9ERZ4 AF NFT

MOLNFT AF v1

NFT data

MOLNFT Q9ERZ4 research and analysis (ICN3D with VR)

FASTA sequences

We use cookies on this site to enhance your user experience